Use of unproven topical pain relief gains more traction in comp: Study
Business Insurance - Aug 27, 2021
Costs for pain-relieving creams for injured workers rose 10% from 2015 to 2019, despite the lack of approval from the Food and Drug Administration for most of the compound drugs, and a dearth of guidelines on use and efficacy, according to a study released Thursday by the Workers Compensation Resear...
Recommended Articles
Posted: Aug 22, 2023
South Korean insurers’ combined net profits increased to around 8 trillion South Korean won ($5.95 b...
Posted: Aug 22, 2023
According to a new report from Aon PLC, South Africa’s insurance market is continuing to see reduced...
Posted: Aug 22, 2023
Independent insurance brokerage Latin RE is the first Brazilian broker to get a license to operate d...